Research
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1857 (Published 24 April 2015) Cite this as: BMJ 2015;350:h1857
Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
Related articles
- Research Published: 04 July 2018; BMJ 362 doi:10.1136/bmj.k2505
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deathsBMJ August 27, 2024, 386 q1871; DOI: https://doi.org/10.1136/bmj.q1871
- Over-the-counter painkillers may not be sufficient when fitting IUDs, says US agencyBMJ August 19, 2024, 386 q1820; DOI: https://doi.org/10.1136/bmj.q1820
- Michael Bloomberg donates $600m to historically black US medical schoolsBMJ August 08, 2024, 386 q1766; DOI: https://doi.org/10.1136/bmj.q1766
- Evaluation and management of hypertensive emergencyBMJ July 26, 2024, 386 e077205; DOI: https://doi.org/10.1136/bmj-2023-077205
Cited by...
- A novel rationale for targeting FXI: Insights from the hemostatic miRNA targetome for emerging anticoagulant strategies
- Uptake of direct oral anticoagulants in primary care: an ecological and economic study
- Interruption and Reversal of Direct Oral Anticoagulants in Preprocedural and Acute Settings
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near-Real-Time Monitoring Program in Italy
- Direct oral anticoagulants versus warfarin: is new always better than the old?
- Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis
- Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study
- Effects of dabigatran according to age in atrial fibrillation
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis
- DTB Select: 2 | February 2017
- Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants
- Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
- Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial
- Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations
- Safety of new oral anticoagulants